Delivery of genes into the CF airway. (2014)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2014-205835
PubMed Identifier: 25015239
Publication URI: http://europepmc.org/abstract/MED/25015239
Type: Journal Article/Review
Volume: 69
Parent Publication: Thorax
Issue: 10
ISSN: 0040-6376